Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

AbbVie shares results from study for new psoriasis therapy

March 20, 2023 Research and Development

AbbVie has announced new 52-week data from a study assessing the efficacy of new IL-23 inhibitor, Skyrizi (risankizumab). Patients with …
News

QurAlis Corporation announces programme which targets UNC13A mis-splicing in neurodegenerative diseases

March 20, 2023 Research and Development

US-based clinical-stage biotechnology QurAlis Corporation has announced the launch of its newest programme to treat neurodegenerative diseases like ALS and …
News

Seamless Therapeutics launches with $12.5m in financing

March 16, 2023 Research and Development

Seamless Therapeutics, a biotech focusing on the therapeutic potential of gene therapies, has announced it received $12.5m (€11.8m) in seed …
News

GSK shares positive results from meningococcal disease vaccine trial

March 14, 2023 Research and Development

GSK has announced positive results from its vaccine candidate trial for meningococcal, which is a significant cause of meningitis and …
News

Occlutech launches FROST-HF study of heart failure device

March 14, 2023 Research and Development

Occlutech has announced that it has recruited its first patient in the FROST-HF study, which aims to investigate the company’s …
News

Acadia Pharmaceuticals awaits FDA decision for first-of-its-kind Rett syndrome drug

March 10, 2023 Research and Development

Acadia Pharmaceuticals is aiming to follow in the footsteps of Reata Pharmaceuticals, who won approval for its novel drug to …
News

Eli Lilly & Co’s Alzheimer’s disease drug fails to stop disease decline

March 9, 2023 Research and Development

Eli Lilly & Co have today announced that its Alzheimer’s disease (AD) hopeful did not slow the progression of cognitive …
News

AstraZeneca shares positive results from Imfinzi trial

March 9, 2023 Research and Development

Pharma giant AstraZeneca has shared positive results from a phase 3 trial on Imfinzi, its resectable non-small cell lung cancer …
News

New clinical trial aims to find new endometriosis treatment

March 8, 2023 Research and Development

A new clinical trial is set to begin shortly which will be a collaboration between the universities of Edinburgh, Aberdeen …
News

Wearable sensor helps detect heart attacks

March 7, 2023 Research and Development

RCE Technologies has developed a bracelet-like device that can measure levels of troponin-I in the patient’s blood, providing a more …
News

Abbott announces positive clinical study data for both TriClip system and MitraClip therapy

March 6, 2023 Research and Development

Abbott has announced positive data from two separate studies, which looked at its TriClip transcatheter edge-to-edge repair (TEER) system and …
News

Lilly receives approval for expanded indication for breast cancer therapy

March 6, 2023 Research and Development

Following positive data from Eli Lilly’s phase 3 monarchE trial, the FDA has granted approval for the expanded indication for …
News

Sanofi and Sobi celebrate completion of XTEND-Kids phase 3 study

March 2, 2023 Research and Development

A collaborative study between Sanofi and Sobi called XTEND-Kids phase 3 has finished, solidifying the first milestone needed for regulatory …
News

BioNxt Solutions signs clinical study agreement and commences clinical samples manufacture for Parkinson’s disease trial

March 1, 2023 Research and Development

BioNxt Solutions, a bioscience accelerator focused on next-generation drug formulations and delivery systems, has announced the finalisation of its comparative …
News

Sequana Medical shares positive results from phase 1 clinical trial

March 1, 2023 Research and Development

Sequana Medical has shared positive results from its phase 1 trial, CHIHUAHUA, assessing the safety and tolerability of a single …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026